Clinical Trial Update: Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a modified stem cell transplant procedure for hematologic neoplasms, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hematologic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2021-09-09